Señales en vivo de C4XD.L | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 abr 2024 @ 12:38):

Stats
Volumen de hoy	27.55M
Volumen promedio	1.20M
Capitalización de mercado	30.27M
EPS	£0.0706 ( Q2 \| 2024-01-31 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	3.00 (Sector) 0 (Industry) 0
ATR14	£1.896 (15.80%)

AMYT.L -11.73%

APH.L 0.39%

AVCT.L 0.27%

AZN.L -0.45%

BMK.L 7.59%

BVXP.L -2.16%

C4XD.L 27.32%

CIR.L 0.00%

CLIN.L 0.11%

DEST.L -2.51%

DPH.L 0.05%

EAH.L 3.49%

ERGO.L 0.15%

ETX.L -6.74%

EVG.L 2.25%

FAB.L -1.59%

FARN.L -5.08%

FUM.L 2.78%

GDR.L 3.03%

GNS.L 1.45%

GSK.L -0.49%

HCM.L -0.36%

HEMO.L -2.75%

HIK.L -0.58%

IMM.L -1.15%

INDV.L 0.32%

IXI.L -5.25%

MTPH.L 1 794.74%

MXCT.L -2.17%

N4P.L -4.71%

NCYT.L -2.48%

NFX.L -4.71%

OBD.L 0.92%

OKYO.L -24.32%

ONC.L 0.45%

OPTI.L -3.75%

OVB.L -2.22%

OXB.L 2.58%

PRM.L -4.82%

PRTC.L 1.42%

PYC.L -6.25%

REDX.L 31.58%

RENE.L -2.17%

SAR.L 6.96%

SCLP.L -1.86%

SLN.L -0.93%

SNG.L 3.48%

STX.L 2.70%

TILS.L 8.33%

TRX.L -1.15%

VAL.L 0.00%

VEC.L 0.00%

Volumen Correlación

Largo: -0.06 (neutral)

Corto: 0.61 (weak)

Signal:(57.209) Neutral

C4X Discovery Holdings Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

C4X Discovery Holdings Correlación - Moneda/Commodity

0.39
( neutral )

0.24
( neutral )

0.40
( neutral )

0.38
( neutral )

-0.30
( neutral )

-0.43
( neutral )

C4X Discovery Holdings Finanzas

Annual	2023
Ingresos:	£1.71M
Beneficio Bruto:	£1.67M (97.78 %)
EPS:	£-0.0442

FY	2023
Ingresos:	£1.71M
Beneficio Bruto:	£1.67M (97.78 %)
EPS:	£-0.0442

FY	2022
Ingresos:	£2.70M
Beneficio Bruto:	£2.57M (95.18 %)
EPS:	£-0.0357

FY	2021
Ingresos:	£5.64M
Beneficio Bruto:	£5.55M (98.40 %)
EPS:	£-0.0400

Financial Reports:

No articles found.

C4X Discovery Holdings Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

C4X Discovery Holdings

C4X Discovery Holdings plc operates as a drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality. The company's product pipeline includes Orexin-1, a receptor antagonist for the treatment of addictive disorders; NRF-2 activator to treat various inflammatory diseases; IL-17A inhibitor for inflammation and autoimmune diseases; a4ß7 integrin inhibitors for the treatment of inflammatory bowel disease; and MALT-1 inhibitors to treat hematological cancer. It has partnerships with Sanofi, GEN-COVID, LifeArc, Indivior PLC, Phoremost, AstraZeneca UK Limited, and Evotec SE. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was incorporated in 2007 and is based in Manchester, the United Kingdom.